Leveraging radiotherapy to improve immunotherapy outcomes: rationale, progress and research priorities
Abstract The most successful immunotherapies for solid malignancies to date, immune checkpoint inhibitors, target the essential role of T cells in antitumor immunity. However, T‐cell dysfunction presents a major hindrance to treatment efficacy, warranting research into combined treatment strategies...
Wedi'i Gadw mewn:
| Prif Awduron: | , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Wiley
2025-01-01
|
| Cyfres: | Clinical & Translational Immunology |
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1002/cti2.70030 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|